Dr. Pettaway on Importance of Inclusive Germline Testing in Prostate Cancer

Video

In Partnership With:

Curtis A. Pettaway, MD, discusses the need to include the genomic data of African American, Asian, and Hispanic men with prostate cancer in national registries.

Curtis A. Pettaway, MD, professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the need to include the genomic data of African American, Asian, and Hispanic men with prostate cancer in national registries.

Although African American men have a higher frequency and mortality of prostate cancer than Caucasian men, there is a lack of data regarding these patients’ germline predisposition to the disease.

Pettaway believes that enrolling these patients in registry trials is key to understanding which men should be tested for genetic alterations in DNA repair genes or genes associated with hereditary cancers, such as BRCA1/2.

Moreover, long-term follow-up of these patients may shed light on gene expressions, clinical outcomes, and clinical variables that are specific to African American, Asian, or Hispanic men.

Additionally, understanding the genetic components of disease could provide insight into more individualized treatment strategies and tailored gene panels.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD